15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Procept Biorobotics Corp, 6 rate it Buy or better, 5 sit at Hold, and 1 rate it Sell or worse, a hold consensus. The target range is very wide, $20.00 to $62.00 (about 3.1x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $37.27 sits 111% above the current $17.70. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.34 next quarter toward $-0.89 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Hold
Strong Buy00%
Buy650%
Hold542%
Sell18%
Strong Sell00%
Based on 12 analysts giving stock ratings to Procept Biorobotics Corp.
As of Jul, 6 of 12 firms rate PRCT a Buy (5 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
PRCT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.34
Range $-0.40 – $-0.30 · 9 analysts · -11% YoY
Next period, 9 analysts expect Procept Biorobotics Corp to earn $-0.34 a share (range $-0.40 – $-0.30), versus $-0.38 a year earlier. Full-year consensus is $-1.54, growing to $-0.89 the year after.
REVENUE · NEXT QUARTER
$102.8M
Range $98.4M – $106.0M · 9 analysts · +23% YoY
Revenue is expected to reach $102.8M (range $98.4M – $106.0M), +23.3% year-over-year. Full-year consensus is $397.5M, rising to $490.5M next year.
Top analysts covering Procept Biorobotics Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PRCT.
#1
Matt O'Brien
Piper Sandler · Rank #356
Buy
$35.00+97.7% to target
Overall win rate
25%
+ Follow
#2
Richard Newitter
Truist Securities
Hold
$25.00+41.2% to target
Coverage
—
+ Follow
#3
NT
Nathan Treybeck
Wells Fargo
Buy
$34.00+92.1% to target
Coverage
—
+ Follow
#4
PW
Patrick Wood
Morgan Stanley
Buy
$51.00+188.1% to target
Coverage
—
+ Follow
#5
Mike Kratky
Leerink Partners
Hold
$29.00+63.8% to target
Coverage
—
+ Follow
PRCT stock forecast FAQ
What is PRCT's average 12-month price target?+
The 10 analysts with a live target average $37.27 for Procept Biorobotics Corp over the next 12 months, ranging from a $62.00 high to a $20.00 low.
Is PRCT stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 12 analyst ratings, 6 are Buy or Strong Buy, 5 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for PRCT?+
The Street-high target is $62.00 (UBS), and the Street-low is $20.00 (B of A Securities). The average of all 10 active targets is $37.27.
How many Wall Street analysts cover PRCT?+
12 analysts have an active rating on Procept Biorobotics Corp, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering PRCT?+
Among analysts who currently cover PRCT, Matt O'Brien of Piper Sandler has the strongest overall Quantellect track record (Rank #356). Their current call is Buy with a $35.00 target.
What is Procept Biorobotics Corp's projected EPS for next quarter?+
The consensus estimate is $-0.34 per share (range $-0.40 – $-0.30) across 9 analysts. Full-year EPS is projected at $-1.54, rising to $-0.89 the following year.
How much revenue is Procept Biorobotics Corp expected to report next quarter?+
Consensus revenue is $102.8M (range $98.4M – $106.0M). Full-year revenue is projected at $397.5M, growing to $490.5M next year.
Have analysts been upgrading or downgrading PRCT lately?+
As of Jul, 6 of 12 firms rate PRCT a Buy (5 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PRCT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
